Management of malignant disease metastatic to bone by hormonal alterations.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000315:Adrenalectomy; D000728:Androgens / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy; D004717:Endometrium; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use*; D006801:Humans; D007016:Hypophysectomy; D007680:Kidney Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008593:Menopause; D008598:Menstruation; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000188:drug therapy; D013964:Thyroid Neoplasms / Q000188:drug therapy; D013972:Thyrotropin / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000728:Androgens; D004967:Estrogens; D012739:Gonadal Steroid Hormones; D013972:Thyrotropin